The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,094,092 in first-year total cost, median $547,046.
Most frequent study sections
- Special Emphasis Panel[ZRG1 DKUS-G (90)]1
- Special Emphasis Panel[ZRG1 IDM-V (12)]1
Most frequent institutions
- BIOCREDE, INC.1
- HYDROMER, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Advanced Nitric Oxide Release Bactericidal Urinary Catheters2R42DK100161-02 | CHEN, HAOMEYERHOFF, MARK E | BIOCREDE, INC., MI | $869,729 | ZRG1 |
| 2014 | Development of a Novel Antimicrobial Foley Catheter to Prevent CAUTIs1R41DK102237-01 | SAVAGE, PAUL BVON DYCK, MARTIN | HYDROMER, INC., NJ | $224,363 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.